The Cannabinoids Market is Projected to Grow to $120.57 Billion by 2030, Expanding at a CAGR of 20.7%

Cannabinoids Market

The Business Research Company's Cannabinoids Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, November 10, 2026 /EINPresswire.com/ -- "The cannabinoids market has witnessed remarkable growth recently, driven by a combination of legal, medical, and societal factors. As interest in cannabinoid-based therapies rises globally, this sector is poised for significant expansion. Let’s explore the current market size, the factors fueling its growth, leading regions, and emerging trends shaping the future of this industry.

Rapid Expansion in Cannabinoids Market Size and Future Outlook
The cannabinoids market is set to increase substantially, growing from $47.03 billion in 2025 to $56.75 billion in 2026, reflecting a robust compound annual growth rate (CAGR) of 20.7%. This historic growth has been propelled by broader legalization of medical cannabis programs, an increase in chronic pain and cancer treatment cases, greater acceptance of alternative therapies, an expansion in hospital pharmacy distribution networks, and the development of standardized cannabinoid products.

Download a free sample of the cannabinoids market report:
https://thebusinessresearchcompany.com/sample_request?id=95048302&type=smp&name=Cannabinoids%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Looking ahead, the market is expected to continue its rapid ascent, reaching $120.57 billion by 2030 while maintaining a CAGR of 20.7%. Key contributors to this anticipated surge include expanded clinical research into cannabinoids, rising demand for pharmaceutical-grade cannabinoid products, clearer regulatory frameworks across global regions, growth in personalized cannabinoid-based medicines, and increased investment in production infrastructure. Significant trends anticipated in the forecast period involve greater medical adoption of cannabinoid therapies, growing popularity of CBD-focused products, wider use of cannabinoids for managing chronic illnesses, strengthening of regulated cannabinoid supply chains, and more stringent focus on product purity and standardization.

Understanding Cannabinoids and Their Medical Use
Cannabinoids are specific chemical compounds derived from marijuana that interact with the immune and central nervous systems, producing drug-like effects. These compounds are commonly used to alleviate symptoms and side effects associated with chronic illnesses such as cancer. Their therapeutic potential has made them a focal point in alternative medicine and pharmaceutical research.

View the full cannabinoids market report:
https://thebusinessresearchcompany.com/report/cannabinoids-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Rising Chronic Disease Rates as a Key Factor Boosting the Cannabinoids Market
One of the main factors driving the cannabinoid market’s growth is the increasing prevalence of chronic diseases, which are conditions lasting a year or more and requiring continuous medical attention. Cannabinoids, including smoked marijuana, cannabis-based medications like oromucosal extracts, nabilone, dronabinol, and new THC analogues, have demonstrated effectiveness in treating chronic noncancer pain, as shown in systematic reviews of randomized controlled trials.

For example, in April 2025, data from the Centers for Disease Control and Prevention (CDC) indicated that, in 2023, around 194 million adults in the United States—about 76.4%—had at least one chronic condition. The breakdown showed that 59.5% of young adults, 78.4% of midlife adults, and 93% of older adults were affected. This widespread prevalence of chronic conditions significantly contributes to the expanding demand for cannabinoid products.

North America Leading the Cannabinoids Market with Asia-Pacific Gaining Momentum
In 2025, North America held the largest share of the global cannabinoids market, driven by progressive legalization policies and well-established healthcare infrastructure. Meanwhile, the Asia-Pacific region is poised to emerge as the fastest-growing market during the forecast period due to increasing regulatory clarity and expanding clinical research.

The cannabinoids market report covers several key regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective on the evolving market landscape.

What’s new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.